MLchartDataset catalogue

dapagliflozin propanediol

Term · Oncology and biomedicine · MLC-T-ONC-012915

The propanediol form of dapagliflozin, a selective sodium-glucose co-transporter subtype 2 (SGLT2) inhibitor with antihyperglycemic activity. Upon administration, dapagliflozin selectively targets and inhibits SGLT2, thereby preventing the reabsorption of glucose by the kidneys.

Table 1. Record
IdentifierMLC-T-ONC-012915
FieldOncology and biomedicine
Synonymsdapagliflozin propylene glycol hydrate; dapagliflozin S-propylene glycol monohydrate
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-012915",
  "term": "dapagliflozin propanediol",
  "field": "Oncology and biomedicine",
  "definition": "The propanediol form of dapagliflozin, a selective sodium-glucose co-transporter subtype 2 (SGLT2) inhibitor with antihyperglycemic activity. Upon administration, dapagliflozin selectively targets and inhibits SGLT2, thereby preventing the reabsorption of glucose by the kidneys.",
  "synonyms": [
    "dapagliflozin propylene glycol hydrate",
    "dapagliflozin S-propylene glycol monohydrate"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/dapagliflozin-propanediol/"
}

Record 5,683 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.